Environmental Science and Pollution Research, Journal Year: 2023, Volume and Issue: 30(52), P. 112433 - 112444
Published: Oct. 13, 2023
Language: Английский
Environmental Science and Pollution Research, Journal Year: 2023, Volume and Issue: 30(52), P. 112433 - 112444
Published: Oct. 13, 2023
Language: Английский
Microorganisms, Journal Year: 2023, Volume and Issue: 11(7), P. 1772 - 1772
Published: July 7, 2023
Desulfovibrio (DSV) are sulfate-reducing bacteria (SRB) that ubiquitously present in the environment and as resident commensal within human gastrointestinal tract. Though they minor residents of healthy gut, DSV opportunistic pathobionts may overgrow setting various intestinal extra-intestinal diseases. An increasing number studies have demonstrated a positive correlation between overgrowth (bloom) While relationship bloom disease pathology has not been clearly established, mounting evidence suggests causal role for these development. As most predominant genera SRB this review summarizes current knowledge regarding variety In study, we also discuss mechanisms by which contribute to pathology.
Language: Английский
Citations
92Environmental Research, Journal Year: 2023, Volume and Issue: 238, P. 117134 - 117134
Published: Sept. 14, 2023
Language: Английский
Citations
28The Science of The Total Environment, Journal Year: 2024, Volume and Issue: 931, P. 172781 - 172781
Published: April 27, 2024
Language: Английский
Citations
11Reviews in Endocrine and Metabolic Disorders, Journal Year: 2023, Volume and Issue: 24(5), P. 839 - 870
Published: April 29, 2023
Obesity has reached epidemic proportion worldwide and in all ages. Available evidence points to a multifactorial pathogenesis involving gene predisposition environmental factors. Gut microbiota plays critical role as major interface between external factors, i.e., diet, lifestyle, toxic chemicals, internal mechanisms regulating energy metabolic homeostasis, fat production storage. A shift composition is linked with overweight obesity, pathogenic bacterial products metabolites (mainly endocannabinoid-related mediators, short-chain fatty acids, bile catabolites of tryptophan, lipopolysaccharides) subsequent alterations gut barrier, altered insulin resistance chronic, low-grade inflammation. Although animal studies point the links an "obesogenic" development different obesity phenotypes, translational value these results humans still limited by heterogeneity among studies, high variation over time lack robust longitudinal adequately considering inter-individual confounders. Nevertheless, available underscores existence several genera predisposing or, conversely, lean metabolically health phenotype (e.g., Akkermansia muciniphila, species from Faecalibacterium, Alistipes, Roseburia). Further using metagenomics, transcriptomics, proteomics, metabolomics exact characterization confounders are needed this field. Results must confirm that distinct specific microbial-derived represent effective precision interventions against long-term.
Language: Английский
Citations
19Food & Function, Journal Year: 2024, Volume and Issue: 15(6), P. 3060 - 3075
Published: Jan. 1, 2024
Lead (Pb) is a widespread toxic endocrine disruptor that could cause liver damage and gut microbiota dysbiosis.
Language: Английский
Citations
8Journal of Agricultural and Food Chemistry, Journal Year: 2024, Volume and Issue: 72(34), P. 18971 - 18985
Published: Aug. 15, 2024
Our previous study showed that heavy metal lead (Pb) exposure exacerbates high-fat-diet (HFD)-induced metabolic damage and significantly depletes the gut microbiota-derived metabolite short-chain fatty acid (SCFA) levels. However, it remains unclear whether SCFA is a key involved in accelerating adverse consequences after Pb exposure. In this study, we explored effects of exogenous supplementation acetate, propionate, butyrate on disorder model Pb-exposed HFD mice. We found three interventions attenuated glycolipid metabolism disorders liver damage, with performing best improving obesity-related symptoms. All promoted abundance
Language: Английский
Citations
6Toxics, Journal Year: 2023, Volume and Issue: 11(8), P. 670 - 670
Published: Aug. 3, 2023
Metabolic syndrome (MetS) is an important public health issue that affects millions of people around the world and growing to pandemic-like proportions. This defined by World Health Organization (WHO) as a pathologic condition characterized abdominal obesity, insulin resistance, hypertension, hyperlipidemia. Moreover, etiology MetS multifactorial, involving many environmental factors, including toxicant exposures. Several studies have associated with heavy metals exposure, which focus this review. Environmental and/or occupational exposure are major risk, contributing development chronic diseases. Of particular note, toxic such mercury, lead, cadmium may contribute altering oxidative stress, IL-6 signaling, apoptosis, altered lipoprotein metabolism, fluid shear stress atherosclerosis, other mechanisms. In review, we discuss known potential roles in well targeted pathways MetS. Furthermore, describe how new approaches proteomic transcriptome analysis, bioinformatic tools, help bring about understanding involvement metalloids
Language: Английский
Citations
15Journal of Hazardous Materials, Journal Year: 2024, Volume and Issue: 471, P. 134360 - 134360
Published: April 19, 2024
Language: Английский
Citations
6Microorganisms, Journal Year: 2024, Volume and Issue: 12(11), P. 2333 - 2333
Published: Nov. 15, 2024
The human gut is a complex ecosystem that supports billions of living species, including bacteria, viruses, archaea, phages, fungi, and unicellular eukaryotes. Bacteria give genes enzymes for microbial host-produced compounds, establishing symbiotic link between the external environment host at both systemic levels. microbiome, which primarily made up commensal critical maintaining healthy host's immune system, aiding digestion, synthesizing essential nutrients, protecting against pathogenic as well influencing endocrine, neural, humoral, immunological functions metabolic pathways. Qualitative, quantitative, and/or topographic shifts can alter resulting in dysbiosis dysfunction, contribute to variety noncommunicable illnesses, hypertension, cardiovascular disease, obesity, diabetes, inflammatory bowel cancer, irritable syndrome. While most evidence date observational does not establish direct causation, ongoing clinical trials advanced genomic techniques are steadily enhancing our understanding these intricate interactions. This review will explore key aspects relationship microbiota, eubiosis, health highlighting emerging strategies microbiome engineering potential therapeutic approaches various conditions.
Language: Английский
Citations
6Toxicology, Journal Year: 2024, Volume and Issue: 503, P. 153751 - 153751
Published: Feb. 13, 2024
Language: Английский
Citations
4